We are passionate about delivering on the promise of organoid technology by developing innovative solutions that are translated into commercial products and therapies for millions of patients worldwide.
Our major areas of focus include the following:
Creation of iPS cells and organoids Biobank that captures population heterogeneity in health and disease.
Pre-clinical Discovery & Development
Creation of fit-for-purpose platforms enabling new target identification, assessment of safety and efficacy, patient stratification. (Disease in a dish, Clinical trial in a dish)
Creation of next generation organoid-based tools for predictive diagnostics. Discovery of new pre-clinical and clinical biomarkers of disease, patient’s outcome and specific drug responses.
Establishment and validation of organoid-based tools for personalized and effective treatment selection. Development of efficient and safe organoid-based therapies across different therapeutic areas.
Scale up & Automation
Development of reliable and highly reproducible products, scalable bioprocesses and applications with automated workflows.
Seamlessly integration of organoid technology in the pharmaceutical industry and clinical practice through joint academic and industrial efforts and early engagement of regulatory authorities.
More Information About CuSTOM Accelerator
If you would like to learn more about CuSTOM Accelerator, partnership, collaboration and career opportunities, contact Magdalena Kasendra at firstname.lastname@example.org.